A note of thanks and an invitation

European Journal of Epidemiology, Dec 2018

Albert Hofman

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs10654-018-0464-y.pdf

A note of thanks and an invitation

European Journal of Epidemiology December 2018, Volume 33, Issue 12, pp 1131–1133 | Cite as A note of thanks and an invitation AuthorsAuthors and affiliations Albert Hofman EDITORIAL First Online: 05 December 2018 370 Downloads At the end of this year, I wish to express my sincere gratitude, also on behalf of the other editors, the members of the editorial board and the publisher of the European Journal of Epidemiology, to the referees of the articles considered for the 2018 volume of EJE. It is no mean feat that hundreds of busy colleagues spend their time in assessing the more than 1100 manuscripts submitted each year to our Journal, in selecting the ones that may possibly be published, and in improving the quality of the selected articles. Many of the reviewers have helped us in the past years as well, and we are tremendously appreciative and grateful to them [1, 2]. It is largely thanks to them that EJE is doing well in attracting and publishing valuable contributions on epidemiologic research findings and epidemiologic methods. Some time ago we have started to publish invited essays on topics of interest to epidemiologists and epidemiology [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31]. I would like to extend an invitation to our readers to submit essays, also without the prompting of an invite. Essays may cover general conceptual and methodologic issues [3, 12, 17, 23, 30, 31] or statistical and data-analytic topics [4, 5, 13, 22]. They may address current concerns [6, 8, 15, 16, 26, 29] or give historical perspectives [14, 19, 25]. The essays may also focus on topical issues in substantive epidemiology [7, 10, 11, 20, 21, 28] or voice societal concerns [7, 26]. We intend to leave the format of these pieces quite open and we hope to receive many creative and forceful contributions, from inside or out of the epidemiology box. Adeline Abbe Anders Ahlbom Krasimira Aleksandrova Silvia Alemany André Amaral Sarah Assaad Anssi Auvinen Mario Bauer Sara Benitez Majano Klaus Berger Maarten Jacob Bijlsma Paolo Boffetta Carl Bonander Hermann Brenner Christian Brettschneider Bert Brunekreef Amanda Buttery Ellen Caniglia Lourdes Cantarero Arevalo Pilar Carrasco-Garrido Chen-Hsin Chen Lori Chibnik Tim Clayton Ramon Cleries Pierluigi Cocco Helen Coleman Anne Marie Colijn Sirwan Darweesh Adrian Davis Inge de Kok Emmely de Roos Olaf Dekkers Cecile Delcourt Klodian Dhana Mirko Di Martino James Doidge Helen Dolk Mariola Drozd Gustaf Edgren Louise Emilsson Simone Eussen Esteve Fernandez Bruno Ferreyro Valentina Gallo Xin Gao Lu Gao Gian Marco Ghiggeri Marija Glisic Stéphanie Goujon Rebecca Graff Sander Greenland Rolf Groenwold Nina Grootendorst Pascal Guénel Mats Hallgren Gaël Paul Hammer Richard Harbron Jane Harding Bernhard Haring Emily Harrison Saima Hilal Albert Hofman Martin Holzmann Chung-Cheng Hsieh José María Huerta Arfan Ikram Kamran Ikram Carmen Jochem Karl-Heinz Joeckel Asa Johansson Igor Karp Maarit Kauppi Maryam Kavousi Nicole Kellow Michelle Kelly-Irving Nikhil Khankari Brenda Kieboom Marjolein Kooijman Lewis Kuller Oliver Kuß Jeremy Labrecque Nasser Laouali Antti Latvala Jack Leiss Catherine Lesko Silvan Licher Longjian Liu Magnus Løberg Annemarie Luik Angela Lupattelli Yuan Ma Ivana Malenica Mohammad Ali Mansournia Elizabeth Rose Mayeda Richard McNally Esther Molina Scott Montgomery Sabine Mous Ryan Muetzel Taulant Muka Ellie Murray Ashley Isaac Naimi Tobias Niedermaier Luke O’Connor Jørn Olsen Clive Osmond Nicolas Pallet Stefania Papatheodorou Raphael Simon Peter Andrea Piccinin Elena Raffetti Parminder Raina Grégoire Rey Jessica Rohmann Matteo Rota Susana Santos Danja Sarink Mary Schooling Stephane Schuck Matthias Schulze Alexander Schuster Lukas Schwingshackl Sylvain Sebert Ingmar Skoog Andreas Stang Denes Stefler Henrik Stovring Bruno Stricker Tores Theorell Liv Cecilie Vestrheim Thomsen Antje Timmer Ali Tiss Esther Toes-Zoutendijk Sergi Trias-Llimós Pietro Trocchi Konstantinos Tsilidis Agnes van der Heide André Verbeek Sanne Verhoog Ellis Voerman Judith Vonk Trudy Voortman Heather Ward Charlotte Warren-Gash Yukari Watanabe Reem Waziry Erich Wichmann Frank Wolters James Yarmolinsky Weimin Ye Anna Zettergren Qingying Zhang References 1. Hofman A. A note of thanks. Eur J Epidemiol. 2016;31(12):1155–1157.  https://doi.org/10.1007/s10654-016-0223-x.CrossRefGoogle Scholar 2. Hofman A. A note of thanks. Eur J Epidemiol. 2017;32(12):1039–1041. https://doi.org/10.1007/s10654-017-0332-1.CrossRefGoogle Scholar 3. Cox D. The design of empirical studies: towards a unified view. Eur J. Epidemiol. 2016;31(3):217–228.  https://doi.org/10.1007/s10654-016-0135-9.CrossRefPubMedGoogle Scholar 4. Greenland S, Senn S, Rothman KJ. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31(4):337–350.  https://doi.org/10.1007/s10654-016-0149-3.CrossRefPubMedPubMedCentralGoogle Scholar 5. Rothman KJ. Disengaging from statistical significance. Eur J Epidemiol. 2016;31(3):443–444.  https://doi.org/10.1007/s10654-016-0158-2.CrossRefPubMedGoogle Scholar 6. Porta M. Caution: work in progress. Eur J Epidemiol. 2016;31(6):535–539.  https://doi.org/10.1007/s10654-016-0181-3.CrossRefPubMedGoogle Scholar 7. Marmot M. Society and health of migrants. Eur J Epidemiol. 2016;31(7):639–641.  https://doi.org/10.1007/s10654-016-0174-2.CrossRefPubMedPubMedCentralGoogle Scholar 8. Kuller LM. The limitations of opportunistic epidemiology, pseudopod epidemiology. Eur J Epidemiol. 2016;31(10):957–966.  https://doi.org/10.1007/s10654-016-0196-9.CrossRefPubMedGoogle Scholar 9. Kuh D. From paediatrics to geriatrics: a life course perspective on the MRC National Survey of Health and Development. Eur J Epidemiol. 2016;31(11):1069–1079.  https://doi.org/10.1007/s10654-016-0214-y.CrossRefPubMedPubMedCentralGoogle Scholar 10. Samet JM. Is there more to learn about the epidemiology of lung cancer? Eur J Epidemiol. 2016;31(12):1159–1160.  https://doi.org/10.1007/s10654-016-0207-x.CrossRefPubMedPubMedCentralGoogle Scholar 11. Adami HO, Nyrén O. Enigmas, priorities and opportunities in cancer epidemiology. Eur J Epidemiol. 2016;31(12):1161–1171.  https://doi.org/10.1007/s10654-016-0218-7.CrossRefPubMedPubMedCentralGoogle Scholar 12. Greenland S. For and against methodologies: some perspectives on recent causal and statistical inference debates. Eur J Epidemiol. 2017;32(1):3–20.  https://doi.org/10.1007/s10654-017-0230-6.CrossRefPubMedPubMedCentralGoogle Scholar 13. Ahlbom A. Significance testing: Why does it prevail? Eur J Epidemiol. 2017:31(1):1–2.  https://doi.org/10.1007/s10654-016-0220-0.CrossRefGoogle Scholar 14. Vandenbroucke JP. Clinical epidemiology: A daydream? Eur J Epidemiol. 2017;32(2):95–101.  https://doi.org/10.1007/s10654-017-0226-2.CrossRefPubMedPubMedCentralGoogle Scholar 15. Galea S. On the potential of academic epidemiology. Eur J Epidemiol. 2017;32(3):169–171.  https://doi.org/10.1007/s10654-017-0233-3.CrossRefPubMedPubMedCentralGoogle Scholar 16. Miettinen OS. On progress in epidemiologic academia. Eur J Epidemiol. 2017;32(3):173–179.  https://doi.org/10.1007/s10654-017-0227-1.CrossRefPubMedPubMedCentralGoogle Scholar 17. Walker AM. Tacit Knowledge. Eur J Epidemiol. 2017;32(4):261–267.  https://doi.org/10.1007/s10654-017-0256-9.CrossRefPubMedPubMedCentralGoogle Scholar 18. Willett WC. Will it be cheese, bologna, or peanut butter? Eur J Epidemiol. 2017;32(4):257–259.  https://doi.org/10.1007/s10654-017-0257-8.CrossRefPubMedPubMedCentralGoogle Scholar 19. Vineis P. From John Snow to omics: the long journey of environmental epidemiology. Eur J Epidemiol. 2018;33(4): 355–363.  https://doi.org/10.1007/s10654-018-0398-4.CrossRefPubMedPubMedCentralGoogle Scholar 20. Hunter DJ. What is in a name? Does cancer subtyping help or hinder in epidemiology research? Eur J Epidemiol. 2017;32(5):349–351.  https://doi.org/10.1007/s10654-017-0274-7.CrossRefPubMedGoogle Scholar 21. Richiardi L, Barone-Adesi F, Pearce N. Cancer subtypes in aetiological research. Eur J Epidemiol. 2017;32(5):353–361.  https://doi.org/10.1007/s10654-017-0253-z.CrossRefPubMedGoogle Scholar 22. Cox DR. Statistical science: a grammar for research. Eur J Epidemiol. 2017;32(6):465–471.  https://doi.org/10.1007/s10654-017-0288-1.CrossRefPubMedPubMedCentralGoogle Scholar 23. Stricker BH. Epidemiology and ‘big data’. Eur J Epidemiol. 2017;32(7):535–536.CrossRefPubMedPubMedCentralGoogle Scholar 24. Marmot M. Social justice, epidemiology and health inequalities. Eur J Epidemiol. 2017;32(7):537–546.  https://doi.org/10.1007/s10654-017-0286-3.CrossRefPubMedPubMedCentralGoogle Scholar 25. Wichmann HE. Epidemiology in Germany—general development and personal experience. Eur J Epidemiol. 2017;32(8):635–656.  https://doi.org/10.1007/s10654-017-0290-7.CrossRefPubMedPubMedCentralGoogle Scholar 26. Sørensen TIA. To see and then to act, that is the challenge. Eur J Epidemiol. 2017;32(9):737–739.  https://doi.org/10.1007/s10654-017-0317-0.CrossRefPubMedPubMedCentralGoogle Scholar 27. Brennan P, Perola M, van Ommen GJ, Riboli E. Chronic disease research in Europe and the need for integrated population cohorts. Eur J Epidemiol. 2017;32(9):741–749.  https://doi.org/10.1007/s10654-017-0315-2.CrossRefPubMedPubMedCentralGoogle Scholar 28. VanderWeele TJ. Religion and health in Europe: cultures, countries, context. Eur J Epidemiol. 2017;32(10):857–861.  https://doi.org/10.1007/s10654-017-0310-7.CrossRefPubMedPubMedCentralGoogle Scholar 29. Rothman KJ. The growing rift between epidemiologists and their data. Eur J Epidemiol. 2017;32(10):863–865.  https://doi.org/10.1007/s10654-017-0314-3.CrossRefPubMedGoogle Scholar 30. Pearce N. Bias in matched case-control studies: DAGs are not enough. Eur J Epidemiol. 2018;33(1):1–4.  https://doi.org/10.1007/s10654-018-0362-3.CrossRefPubMedPubMedCentralGoogle Scholar 31. Mansournia MA, Jewell PN, Greenland S. Case-control matching: effects, misconceptions, and recommendations. Eur J Epidemiol. 2018;33(1):5–14.  https://doi.org/10.1007/s10654-017-0325-0.CrossRefPubMedPubMedCentralGoogle Scholar Copyright information © Springer Nature B.V. 2018 Authors and Affiliations Albert Hofman1Email author1.BostonUSA


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs10654-018-0464-y.pdf

Albert Hofman. A note of thanks and an invitation, European Journal of Epidemiology, 2018, 1131-1133, DOI: 10.1007/s10654-018-0464-y